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INTRODUCTION
Atopic dermatitis (AD) is a chronic and relapsing pruritic infl-
ammatory skin disease, often associated with elevated serum 
IgE levels and a family history of AD, allergic rhinitis, and asth-
ma.1,2 The prevalence of AD in industrialized countries has re-
cently increased to 15 to 30% in children and 2 to 10% in adults.3 
AD has a complex etiology with genetic, immunological, and 
environmental aspects. Mutations in the filaggrin gene (FLG) 
are the most common and significant genetic defects identified 
to date causing AD, emphasizing the role of skin barrier alter-
ations in AD pathogenesis.1,4-6
FLG was first identified by Dale7 in 1977 as a highly insoluble, 
histidine-rich protein that was co-purified with keratin inter-
mediate filament proteins in epidermal extracts. FLG mono-
mers have been thought to promote corneocyte compaction by 
contributing to keratin pattern formation in the lower stratum 
corneum (SC).4 FLG monomers are proteolyzed into natural 
moisturizing factors, which are necessary to maintain hydra-
tion of the upper SC and acidic pH of the skin surface.1
FLG mutations have been identified as the underlying cause 
of ichthyosis vulgaris8 (IV; OMIM 146700), which is character-
ized by dry and scaly skin, palmar and plantar hyperlinearity, 
and keratosis pilaris.9 Furthermore, FLG mutations have proved 
to be a major predisposing factor for AD in Europe and Asia.6,10 
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Patients with AD who carry FLG mutations have been reported 
to have more persistent and severe disease, a higher incidence 
of herpes virus infection, allergic sensitization, and a greater 
risk of multiple allergies than patients with AD without FLG 
mutations.1,5
Some FLG mutations (R501X, R1891X, 3321delA, S1405X, 
S1515X, W1947X, G2025X, E3070X, Q1701X, Y1767X, S3296X, 
and K4022X) have been identified in Korea.11-14 This study 
aimed to examine the spectrum of FLG-null mutations in Kore-
ans with AD to investigate the association between FLG muta-
tions and clinical AD markers and to compare the landscape of 
Korean FLG mutations with that of other Asian countries.
MATERIALS AND METHODS
Clinical materials
Seventy Korean patients with AD whose parents and all four 
grandparents were recorded as ethnic Korean were enrolled. 
Diagnosis of AD was confirmed by experienced dermatologists 
using AD diagnostic criteria created by Hanifin and Rajka.15 
Patients were divided into three groups according to age of on-
set: early childhood onset (<8 years), late childhood onset (8–
18 years), and adult onset (>18 years). AD disease severity was 
assessed using the SCORing Atopic Dermatitis (SCORAD) in-
dex, and patients with AD were grouped into mild (<15 points), 
moderate (15–40 points), and severe (>40 points) disease gro-
ups.16 Peripheral blood samples were analyzed for total serum 
IgE levels and specific IgE levels for egg, milk, soybean, pea-
nut, fish, wheat, mites (Dermatophagoides pteronyssinus, Der-
matophagoides farinae), and cockroach by multiple allergo-
sorbent test chemiluminescent assay (MAST-CLA; Advan-
SureTM AlloStation, LG Life Science, Seoul, Korea). Total IgE 
concentrations ≥200 KIU/L and/or ≥3+ in three categories of 
the MAST-CLA test were arbitrarily defined as elevated IgE in 
this study.17,18 Associated allergic diseases, including asthma 
and allergic rhinitis, were determined on the basis of the ques-
tionnaire and previous diagnoses by physicians. Patients pro-
vided written informed consent, which complied with the prin-
ciples of the Declaration of Helsinki. This study was approved 
by the Institutional Review Board (IRB No. 3-2014-0027) of Ga-
ngnam Severance Hospital, Seoul.
Mutation analysis
Genomic DNA was extracted from peripheral blood leukocytes 
with a DNA extraction kit (QIAamp DNA Blood Midi kit, Qia-
gen, Hilden, Germany). Patients with AD were screened for 
fourteen FLG mutations that have been identified in Korea, Ja-
pan, and China (R501X, 3321delA, S1695X, Q1701X, Q1745X, 
Y1767X, Q1790X, S2554X, S2889X, S3296X, 3222del4, S1515X, 
Q2417X, and K4022X) by direct DNA sequencing as described 
previously.19,20
Statistical analysis
Descriptive statistics for quantitative values were expressed as 
means [±standard deviation (SD)] in accordance with the data 
distribution. Frequencies and percentages were used to de-
scribe categorical variables. We used Fisher’s exact test to assess 
the associations between FLG mutations and AD, as well as 
AD-associated phenotypes, including age of onset of AD, SCO-
RAD index, allergic AD, family history of AD, and associated al-
lergic diseases like asthma and allergic rhinitis. The strength of 
associations was estimated by calculating odds ratios and 95% 
confidence intervals. The level of statistical significance was es-
tablished at α<0.05. Statistical analyses were performed using 
SPSS version 19 (SPSS Inc., Chicago, IL, USA).
Table 1. Clinical Characteristics of Korean Patients with AD in This Study
Characteristics Number of patients (%)
Total AD patients 70 
Mean age (yrs) 19.3 (range 0–63)
Sex
Male 48 (68.6)
Female 22 (31.4)
Elevated IgE* 44 (62.8)
Hyperlinear palms 17 (24.2)
Age of onset (yrs)
Early childhood (<8) 53 (75.7)
Late childhood (8–18) 10 (14.3)
Adult (>18) 7 (10.0)
Family history 28 (40.0)
Allergic disease association† 25 (35.7)
Severity (SCORAD index)
Mild (<15 points) 13 (18.6)
Moderate (15–40 points) 25 (35.7)
Severe (>40 points) 32 (45.7)
AD, atopic dermatitis; SCORAD, SCORing Atopic Dermatitis.
*Total IgE ≥200 KIU/L and/or specific IgE ≥3+, †Allergic disease: allergic rhi-
nitis and/or asthma.
Table 2. Atopic Dermatitis Association Analysis for FLG Null Variants in Korea
Genotype R501X 3321delA Y1767X S1695X Q1701X Q1745X Q1790X S2554X S2889X S3296X K4022X 3222del4 S1515X Q2417X
AA 70 64 70 70 70 70 70 70 69 68 67 70 70 70
Aa 0 6 0 0 0 0 0 0 1 2 3 0 0 0
aa 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total 70 70 70 70 70 70 70 70 70 70 70 70 70 70
FLG, filaggrin gene.
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RESULTS
Clinical features 
The clinical characteristics of patients with AD are presented in 
Table 1. A total of 70 patients were enrolled in this study. The 
mean age was 19.3 years (range 0 to 63, SD=13.14), and 68.6% of 
patients were male. Thirteen patients had mild AD, 25 had mod-
erate, and 32 had severe AD, as determined by the SCORAD in-
dex. Fifty-seven (81.4%) patients had moderate to severe disease. 
In the AD cohort, 24.3% of patients had hyperlinear palms.
FLG mutations in AD patients 
Among the fourteen mutations screened, four, S2889X, S3296X, 
3321delA, and K4022X, were identified in our AD patients (Table 
2, Fig. 1). Eleven patients had FLG mutations, and all were het-
erozygous for the mutation. All patients with FLG mutations had 
moderate to severe AD (Fig. 2). Mutations 3321delA, K4022X, 
S3296X, and S2889X were carried by six (9.1%), three (4.5%), two 
(3.0%), and one (1.5%) individuals, respectively. One patient was 
a heterozygous carrier of two different FLG mutations. This 
study is the first time S2889X has been identified in Koreans 
with AD (Fig. 1).
Associations between FLG mutations and 
AD characteristics
FLG mutations were significantly associated with elevated IgE, 
palmar hyperlinearity, and a family history of allergic disease 
(p<0.05) (Table 3). All patients with FLG mutations had high 
IgE, and were positive for MAST-CLA or moderate to severe AD. 
Palmar hyperlinearity was present in eight patients (72.7%) 
with AD and FLG mutations. Eight patients (72.7%) with FLG 
mutations had a family history of allergic disease. Age of onset 
was not significantly associated with FLG mutation. AD severity 
was not statistically significantly associated with FLG mutation 
(p=0.115).
Clinical phenotype differences among each FLG mutations 
are shown in Table 4 and Fig. 3. Although clinical severity and 
phenotypic expression tended to differ among mutation types, 
statistical significance was not reached since the number of 
patients was too small.
Fig. 2. Clinical features of patients with atopic dermatitis. (A) Palmar hyperlinearity of an atopic dermatitis patient with mutation K4022X. (B) Fine scales and 
xerosis on the trunk of a patient with mutations S2889X and S3296. (C) Erythematous papules and a patch on the back of a patient with mutation 3321delA.
A B C
Fig. 1. FLG mutations detected in patients with atopic dermatitis. (A) A het-
erozygous deletion mutation, 3321delA, in FLG repeat 2 in exon 3 was 
identified in patient no. 28. (B) Two heterozygous transition mutations, 
c.8666C→G and c.8667C→ A, in patient no. 11 resulted in S2889X. (C) A 
heterozygous transition mutation, c.9887C→A, in patient no. 66 resulted in 
S3296X. (D) A heterozygous transition mutation, 14011A→T, in patient no. 
40 resulted in nonsense mutation K4022X. FLG, filaggrin gene.
3321delA heterozygoteA
S3296X heterozygoteC
S2889X heterozygoteB
K4022X heterozygoteD
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DISCUSSION
Since two FLG mutations, R501X and 2282del4, were identified 
in Europeans with AD, many replication studies have reported 
the prevalence and frequency of mutations in the FLG in indi-
viduals with AD.9,10 New FLG mutations associated with AD 
have been widely reported in European and non-European co-
horts. Previous reports have also shown variations in FLG mu-
tations among individuals with AD in different ethnic groups. 
The most prevalent FLG mutations are R501X and 2282del4 
and have been reported to be present in up to 48% of Europe-
ans with AD.1,5 The mutation landscape in Asians with AD co-
horts has been reported to vary, and the frequency was report-
ed to be much lower than that in Europeans. Although many 
European countries have a similar FLG mutation landscape, 
Asian countries have been reported to have distinct FLG mu-
tation landscapes. Among the Asian-specific FLG null muta-
tions identified in Japan, China, Taiwan, and Singapore, only 
3321delA was common. In a Japanese AD cohort, the S2554X 
and S2889X mutations were the most prevalent, followed by 
3321delA and S3296X.21,22 3321delA and K4671X were the 
most common FLG mutations in an AD cohort in China.23,24 
Hsu, et al.25 identified three FLG mutations, 3321delA, Q2417X, 
and E1795X, in Taiwanese families with ichthyosis vulgaris. 
The 3321delA mutation was the most prevalent FLG mutation 
in Singapore.26
In this study, fourteen FLG mutations, R501X, 3321delA, 
S1695X, Q1701X, Q1745X, Y1767X, Q1790X, S2554X, S2889X, 
Table 3. Clinical Characteristics of Korean Patients with AD and with or without FLG Mutations
Characteristic AD with FLG mutations (%) AD without FLG mutations (%) p value
Number of patients 11 59 -
Age (range), yrs 28 (0–63) 18 (0–43) -
Sex 
Male 8 (72.7) 40 (67.8) -
Female 3 (27.3) 19 (32.2) -
Elevated IgE* 11 (100) 33 (55.9) 0.005
Hyperlinear palms 8 (72.7) 9 (15.3) <0.001
Age of onset (yrs) 0.545
Early childhood (< 8) 8 (72.7) 45 (76.3)
Late childhood (8–18) 1 (9.1) 9 (15.3)
Adult (>18) 2 (18.2) 5 (8.5)
Family history of allergic disease 8 (72.7) 20 (33.4) 0.021
Allergic disease association† 4 (36.4) 21 (35.6) 1.000
Severity (SCORAD index) 0.115
Mild (<15 points) 0 (0) 13 (22.0)
Moderate (15–40 points) 3 (27.3) 22 (27.3)
Severe (>40 points) 8 (72.7) 24 (40.7)
FLG, filaggrin gene; AD, atopic dermatitis; SCORAD, SCORing Atopic Dermatitis.
*Total IgE ≥200 KIU/L and/or specific IgE ≥3+, †Allergic disease: allergic rhinitis and/or asthma.
Table 4. Clinical Characteristics of Korean Patients with Atopic Dermatitis and with FLG Mutations
FLG mutation Patient number Scorad score Hyperlinear palm
Family history of 
allergic disease
Allergic disease 
association
IgE
(KIU/L) 
Age of 
onset (yrs)
3321delA
16 59 Yes Yes No 377 62
24 28 No Yes No 68.4 0
28 23 No Yes No 30.6 0
34 36 Yes Yes Yes >1000.0 8
48 54 Yes Yes Yes >1000.0 5
63 50 Yes Yes Yes 4119 1
K4022X
5 57 No No Yes >1000.0 0
33 41 Yes No No 167 5
40 69 Yes No No >1000.0 31
S3296X
11 68 Yes Yes No 405 7
67 49 Yes Yes No 2124 0
S2889X 11 68 Yes Yes No 405 7
FLG, filaggrin gene.
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S3296X, 3222del4, S1515X, Q2417X, and K4022X, which previ-
ously were reported in Asian AD cohorts, were selected for FLG 
mutation analysis. We demonstrated that 15.7% of Koreans with 
AD in our study had four FLG null mutations: S2889X, S3296X, 
3321delA, and K4022X. 3321delA (n=6, 9.1%) was the most 
common FLG mutation in our AD cohort followed by K4022X 
(n=3, 4.5%). This prevalence is similar to that in China; 3321delA 
is one of the most prevalent mutations in Chinese patients with 
AD.24 In a recent study, Park, et al.14 screened 81 Korean AD pa-
tients and K4022X was the most common. We also found that 
K4022X was the second most common mutation in our cohort; 
therefore, K4022X is thought to be a common mutation in Ko-
reans with AD. There were differences of prevalent FLG muta-
tions and AD-associated phenotype between the previously 
published two studies. Park, et al.14 reported new FLG muta-
tions in Korean AD patients by analyzing coding exons, where-
as we analyzed known mutations. The differences in FLG mu-
tations and AD-associated phenotype may be the result of 
small sample size in both studies.
S2889X (n=1, 1.5%) and S3296X (n=2, 3.1%), which are com-
mon in Japanese patients with AD, were also detected in two 
Koreans in our study. S2554X, which was the most common 
FLG mutation in Japan, was not detected in our study. One 
patient who had two mutations, S2889X and S3296X, had hy-
perlinear palms, clinical features of IV, and severe AD. Notably, 
this study was the first to detect the S2889X mutation in Kore-
ans. This study expanded our understanding of the landscape 
of FLG-null mutations in Koreans with AD.
The frequency of FLG mutation was 31.4% and 26.0% in Chi-
nese patients with AD in previous reports.23,24 A Japanese case–
control study of eight FLG mutations demonstrated that about 
27% of Japanese patients with AD carried at least one FLG mu-
tation.22 The frequency of FLG mutations was 20.2% in Singa-
porean Chinese patients with AD or IV.26 In our study, the fre-
quency of FLG mutations in Korean patients with AD (15.7%) 
was similar to that reported by Park, et al.14 The frequency of 
FLG mutations in Koreans with AD seems to be lower than that 
in other Asian countries. The low frequency of FLG mutations 
in our study can be explained by the fact that AD is a multifac-
torial disease that is affected by genetic and environmental 
factors. Mutations in other barrier-related genes may contrib-
ute to AD in our cohort. In addition, decreased FLG expression 
in AD as a result of genetic mutations or skin inflammation can 
induce acquired FLG deficiency. Barrier impairment in AD pa-
tients with severe inflammation has been reported to be similar 
in patients with wild-type and mutant FLG. These FLG altera-
tions due to inflammation can also explain the low FLG muta-
tion frequency in individuals with AD.5,27 The other important 
finding of our study is the association between FLG mutations 
and clinical features of AD in the Korean population. Palmar 
hyperlinearity and allergic sensitization with increased total IgE 
levels have been previously reported to be strongly associated 
with mutant FLG.26,28 A significant association between palmar 
hyperlinearity and FLG mutations was also observed in our 
study. Previously, associations between FLG mutations and AD 
severity have been reported.26 In contrast, other groups did not 
identify an association between FLG mutations and disease se-
verity or skin barrier defects, characterized by high transepi-
dermal water loss.21,23,24 Although AD has been reported to be 
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more severe in patients with FLG mutations, there were no sig-
nificant associations between FLG mutations and AD severity in 
our study. The lack of association between FLG mutations and 
AD severity maybe due to the fact that the SCORAD is a momen-
tary variable that does not reflect overall disease activity.29
Any associated between early-onset AD and FLG mutations is 
still controversial. FLG mutations are related to early onset and 
persistent AD.30 However, Meng, et al.31 did not find an associa-
tion between early-onset AD and the FLG mutation 3321delA. 
Age of onset was also not significantly associated with FLG mu-
tations in the present study.
In conclusion, our study expands our understanding of the 
landscape of FLG mutations in Koreans by finding four FLG 
mutations, of which one has not previously been reported in 
Koreans with AD. We also found that the frequency of FLG mu-
tations in Korean AD was lower than that of other Asian coun-
tries. The FLG mutation spectrum in our cohort was both dis-
tinct and partially overlapping with other Asian AD cohorts. We 
also demonstrated a significant association between FLG mu-
tations and AD phenotype (elevated IgE, palmar hyperlinearity, 
and a family history of allergic disease).
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